Researcher.Life Logo

Drug Metabolism and Personalized Therapy : Impact Factor & More

eISSN: 2363-8915pISSN: 2363-8907

Key Metrics

CiteScore
2.9
H-Index
37
SJR
Q2Pharmacology (medical)
SNIP
0.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WALTER DE GRUYTER GMBH
Frequency Quarterly
General Details
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Metabolism and Personalized Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Metabolism and Personalized Therapy

Drug metabolism and personalized therapy is switching its publication model to open access.
  • 7 Apr 2026
  • Drug metabolism and personalized therapy
Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).
  • 13 Mar 2026
  • Drug metabolism and personalized therapy
CYP2C19 genetic polymorphisms and proton pump inhibitor therapy resistance in patients with gastrooesophageal reflux disease: a preliminary observational cohort study.
  • 26 Feb 2026
  • Drug metabolism and personalized therapy
The molecular landscape of kidney stone disease: pathophysiology to personalized intervention.
  • 26 Feb 2026
  • Drug metabolism and personalized therapy
Allergy to muscle relaxants: diagnosis and significance of drug concentrations.
  • 25 Feb 2026
  • Drug metabolism and personalized therapy
Application of herbal liniment ('Ṭilā) in the management of pain and disability of chronic migraine: a randomized controlled trial.
  • 2 Feb 2026
  • Drug metabolism and personalized therapy
Drug metabolism and personalized therapy is switching its publication model to open access.
  • 7 Apr 2026
  • Drug metabolism and personalized therapy
Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).
  • 13 Mar 2026
  • Drug metabolism and personalized therapy
CYP2C19 genetic polymorphisms and proton pump inhibitor therapy resistance in patients with gastrooesophageal reflux disease: a preliminary observational cohort study.
  • 26 Feb 2026
  • Drug metabolism and personalized therapy
The molecular landscape of kidney stone disease: pathophysiology to personalized intervention.
  • 26 Feb 2026
  • Drug metabolism and personalized therapy
Allergy to muscle relaxants: diagnosis and significance of drug concentrations.
  • 25 Feb 2026
  • Drug metabolism and personalized therapy
Application of herbal liniment ('Ṭilā) in the management of pain and disability of chronic migraine: a randomized controlled trial.
  • 2 Feb 2026
  • Drug metabolism and personalized therapy

FAQs on Drug Metabolism and Personalized Therapy